ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
What can we do to enhance cognitive care in Parkinson's disease?
Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Barriers and enablers to cognitive assessment in Parkinson's disease: A qualitative contextual inquiry.Journal of Parkinson's disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For people living with Parkinson's disease (PD), cognitive impairment is a salient concern. The cumulative risk of mild cognitive impairment and dementia increases as the disease progresses, which contributes to loss of functional independence and increased institutionalization at late stages of PD. Yet, due to scarcity of time and resources, cognition is often an overlooked topic in busy neurology clinics. There are few opportunities for cognitive evaluation during clinical consults, and where it does occur, assessment methods are varied and unstandardized. Diagnostic and post-diagnostic care pathways for cognitive decline vary across clinical services, leaving people with PD falling through the resonant cracks of our healthcare systems. This perspective article highlights current gaps and inconsistencies in the diagnosis, evaluation, and management of cognitive disorders in PD. In doing so, we explore ways in which some of these issues may be rectified through best practice guidelines and critically analyze those that are more difficult to address.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.